News & Events – Page 11 – www.brainwork.md

Brainwork-DiabeticDrugMayBenefitHigh-RiskStrokePatients

25th October 2017

Diabetes drug may benefit high-risk stroke patients

https://www.brainwork.md/content/uploads/2017/10/Brainwork-DiabeticDrugMayBenefitHigh-RiskStrokePatients.jpg 4064 2710 Camilla Norrmén, PhD Camilla Norrmén, PhD https://secure.gravatar.com/avatar/c5fc8d4c102d9ee8db3f93d7f9c6ecd2?s=96&d=mm&r=g 25th October 2017 13th July 2018

A study showed last year that the insulin-sensitizing drug pioglitazone reduces the risk for stroke in patients with recent ischemic strokes. A new secondary analysis…

Camilla Norrmén, PhD
0
0

24th October 2017

NAVIGATE ESUS: Rivaroxaban vs aspirin study terminated due to comparable efficacy

https://www.brainwork.md/content/uploads/2017/10/Brainwork-NavigateESUS.jpg 2992 2000 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 24th October 2017 13th July 2018

Early discontinuation has been announced for the Phase III NAVIGATE ESUS study – led by Bayer AG and its development partner Janssen Research & Development,…

Peter Stevenson, PhD
0
0

​Diabetes drug may benefit high-risk stroke patients

​NAVIGATE ESUS: Rivaroxaban vs aspirin study terminated due to comparable efficacy

Diabetes drug may benefit high-risk stroke patients

NAVIGATE ESUS: Rivaroxaban vs aspirin study terminated due to comparable efficacy